Literature DB >> 30159583

[Resection strategies for adrenocortical carcinoma].

S Schimmack1, O Strobel2.   

Abstract

Adrenocortical carcinomas (ACC) are rare and aggressive neoplasms. Due to their high rate of local recurrence and distant metastases (up to 85%) they are associated with a poor survival. The 5‑year survival in ACC patients with lymph node metastasis or local infiltration is 50% and with distant metastasis less than 15%. An R0 resection with locoregional and para-aortic/paracaval lymphadenectomy is the only curative option and reasonable treatment possibility. The treatment of these patients should therefore be planned and carried out in centers. Local recurrences and distant metastases should also be treated with R0 resection when feasible, combined with neoadjuvant/adjuvant chemotherapy and/or radiation. In the case of an asymptomatic non-resectable ACC, debulking operations cannot be recommended. The primary operation can also be done in a minimally invasive procedure if principles of oncological surgery are followed (radical resection, no damage of the tumor capsule, lymphadenectomy), since survival after open and minimally invasive laparoscopic resection was comparable. Palliative resections are only indicated in symptomatic patients.

Entities:  

Keywords:  Adrenalectomy; Lymphadenectomy; Oncologic principles; R0 resection; Recurrence

Mesh:

Year:  2019        PMID: 30159583     DOI: 10.1007/s00104-018-0712-4

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  1 in total

1.  Multidisciplinary team therapy for left giant adrenocortical carcinoma: A case report.

Authors:  Zheng Zhou; Hong-Mei Luo; Jian Tang; Wu-Jun Xu; Bin-Hui Wang; Xu-Hui Peng; Heng Tan; Li Liu; Xiang-Yang Long; Yu-De Hong; Xiao-Bin Wu; Jian-Ping Wang; Bai-Qi Wang; Hai-Hui Xie; Yong Fang; Yong Luo; Rong Li; Yi Wang
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.